Spinifex to be acquired by Novartis
Australian pain drug innovation company sold to Novartis for US$200m plus milestone payments
02-Jul-2015 -
Spinifex Pharmaceuticals, Inc. and its Australian subsidiary Spinifex Pharmaceuticals Pty Ltd, a company focused on the development of new drugs for the treatment of chronic pain, announced agreement to the sale of Spinifex to Novartis International AG, for an upfront cash consideration of US$200 ...
acquisitions
chronic pain
Novartis